11
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Peripheral and Prostatic Vein Steroid Concentrations in Benign Prostatic Hypertrophy Patients Before and After Removal of the Adenoma

, , &
Pages 225-227 | Received 23 Sep 1979, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Karel De Caestecker, Nicolaas Lumen, Anne-Françoise Spinoit, Karel Everaert, Tom Fiers & Willem Oosterlinck. (2016) Varicocele: the origin of benign prostatic hypertrophy? Testosterone dosages in the periprostatic plexus. Acta Clinica Belgica 71:5, pages 281-283.
Read now

Articles from other publishers (20)

Shunichi Namiki, Koji Mitsuzuka, Yasuhiro Kaiho, Shigeyuki Yamada, Hisanobu Adachi, Shinichi Yamashita, Hideo Saito, Akihiro Ito, Haruo Nakagawa, Misa Takegami & Yoichi Arai. (2016) Serum luteinizing hormone concentration is significantly associated with recovery of urinary function after radical prostatectomy. BJU International 117:3, pages 450-455.
Crossref
Boris Gershman, Irene M. Shui, Meir Stampfer, Elizabeth A. Platz, Peter H. Gann, Howard L. Sesso, Natalie DuPre, Edward Giovannucci & Lorelei A. Mucci. (2014) Prediagnostic Circulating Sex Hormones Are Not Associated with Mortality for Men with Prostate Cancer. European Urology 65:4, pages 683-689.
Crossref
Al V. Taira, Gregory S. Merrick, Robert W. Galbreath, Wayne M. Butler, Jonathan H. Lief, Zachariah A. Allen & Kent E. Wallner. (2012) Serum Testosterone Kinetics After Brachytherapy for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 82:1, pages e33-e38.
Crossref
Andrea Salonia, Andrea Gallina, Alberto Briganti, Firas Abdollah, Nazareno Suardi, Umberto Capitanio, Renzo Colombo, Massimo Freschi, Patrizio Rigatti & Francesco Montorsi. (2011) Preoperative hypogonadism is not an independent predictor of high‐risk disease in patients undergoing radical prostatectomy. Cancer 117:17, pages 3953-3962.
Crossref
Bo Sung ShinEu Chang HwangChang Min ImSun-ouck KimSeung Il JungTaek Won KangDong Deuk KwonKwangsung Park & Soo Bang Ryu. (2010) Is a Decreased Serum Testosterone Level a Risk Factor for Prostate Cancer? A Cohort Study of Korean Men. Korean Journal of Urology 51:12, pages 819.
Crossref
Jean Fiet & Frank Giton. (2010) Circulating steroid hormones in prostate carcinogenesis. Part 1 – Androgens. Hormone Molecular Biology and Clinical Investigation 3:1.
Crossref
Takashi Imamoto, Hiroyoshi Suzuki, Takanobu Utsumi, Takumi Endo, Makoto Takano, Masashi Yano, Koji Kawamura, Naoto Kamiya, Naoki Nihei, Yukio Naya & Tomohiko Ichikawa. (2009) Association between serum sex hormone levels and prostate cancer: effect of prostate cancer on serum testosterone levels. Future Oncology 5:7, pages 1005-1013.
Crossref
T Imamoto, H Suzuki, M Yano, K Kawamura, N Kamiya, K Araki, A Komiya, Y Naya, T Shiraishi & T Ichikawa. (2008) Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?. Prostate Cancer and Prostatic Diseases 12:1, pages 78-82.
Crossref
Takashi Imamoto, Hiroyoshi Suzuki, Masashi Yano, Koji Kawamura, Naoto Kamiya, Kazuhiro Araki, Akira Komiya, Naoki Nihei, Yukio Naya & Tomohiko Ichikawa. (2008) The role of testosterone in the pathogenesis of prostate cancer. International Journal of Urology 15:6, pages 472-480.
Crossref
Shinya Yamamoto, Junji Yonese, Satoru Kawakami, Yuhei Ohkubo, Manabu Tatokoro, Yoshinobu Komai, Hideki Takeshita, Yuichi Ishikawa & Iwao Fukui. (2007) Preoperative Serum Testosterone Level as an Independent Predictor of Treatment Failure following Radical Prostatectomy. European Urology 52:3, pages 696-701.
Crossref
Yoshitaka Sekine, Kazuto Ito, Takumi Yamamoto, Haruki Nakazato, Yasuhiro Shibata, Motoaki Hatori & Kazuhiro Suzuki. (2007) Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan. Cancer Detection and Prevention 31:2, pages 149-153.
Crossref
Arno W. F. T. Toorians, Sharyn Kelleher, Louis J. Gooren, Mark Jimenez & David J. Handelsman. (2003) Estimating the Contribution of the Prostate to Blood Dihydrotestosterone. The Journal of Clinical Endocrinology & Metabolism 88:11, pages 5207-5211.
Crossref
Sonia Chalbot, Catherine Trap, Jean-Paul Monin & Robert Morfin. (2002) Use of bioconversion for the preparation of [4-14C]-labeled 7α- and 7β-hydroxylated derivatives of dehydroepiandrosterone and epiandrosterone. Steroids 67:13-14, pages 1121-1127.
Crossref
Geoffrey L Hammond. (2002) Access of reproductive steroids to target tissues. Obstetrics and Gynecology Clinics of North America 29:3, pages 411-423.
Crossref
Georg Schatzl, Stephan Madersbacher, Thomas Thurridl, Julia Waldmüller, Gero Kramer, Andrea Haitel & Michael Marberger. (2001) High‐grade prostate cancer is associated with low serum testosterone levels. The Prostate 47:1, pages 52-58.
Crossref
Pierre Lafaye, Valérie Chmielewski, Farida Nato, Jean-Claude Mazié & Robert Morfin. (1999) The 7α-hydroxysteroids produced in human tonsils enhance the immune response to tetanus toxoid and Bordetella pertussis antigens. Biochimica et Biophysica Acta (BBA) - General Subjects 1472:1-2, pages 222-231.
Crossref
LESLIE R. MILLER, ALAN W. PARTIN, DANIEL W. CHAN, DEBRA J. BRUZEK, ADRIAN S. DOBS, JONATHAN I. EPSTEIN & PATRICK C. WALSH. (1998) INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS. The Journal of Urology, pages 449-453.
Crossref
LESLIE R. MILLER, ALAN W. PARTIN, DANIEL W. CHAN, DEBRA J. BRUZEK, ADRIAN S. DOBS, JONATHAN I. EPSTEIN & PATRICK C. WALSH. (1998) INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS. Journal of Urology 160:2, pages 449-453.
Crossref
Nicholas J. Bolton, Reijo Vihko & Olavi Lukkarinen. (2006) Concentrations of androgens in human benign prostatic hypertrophic tissues incubated for up to three days. The Prostate 9:2, pages 159-167.
Crossref
O. LUKKARINEN. (1980) Total and SHBG-bound Testosterone and 5α-Dihydrotestosterone Serum Concentrations in Normal Elderly Men and Patients with Benign Prostatic Hypertrophy Before and After Removal of the Adenoma. British Journal of Urology 52:5, pages 377-380.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.